Tirzepatide 30mg

Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed by Eli Lilly and Company. Unlike single-receptor peptides, it binds to both pathways to synergistically regulate blood sugar and metabolic pathways. It is the active ingredient in FDA-approved commercial medications like Mounjaro® and Zepbound®.

Important Compliance Notice: When sold as a raw research chemical or lyophilized peptide outside of official brand-name prescription channels, Tirzepatide is strictly restricted to in vitro laboratory research and educational evaluation. It cannot be legally sold or marketed for human or veterinary consumption.